Dr. Korman is Senior Vice President of Human Immunology at Vir Biotechnology. Previously, he was Vice President for Immuno-Oncology Discovery at Bristol-Myers Squibb (BMS), where he led the development of biologics for tumor immunotherapy. Prior to BMS, he held various positions at Medarex. His tenure at BMS and Medarex led to the development of two […]
Prof. Markel is a Clinician and basic researcher, he is the Chief Scientist of the Ella Lemelbaum Institute for Immuno-Oncology, Sheba medical center and Associate Professor of Immunology (Tel Aviv University). Prof. Markel is an expert in Immuno-Oncology with broad experience in integrative platforms, including genetics, cell biology, animal models and immunology. He is the […]
Clinical consultant and SAB member, Deputy Director of the Perlmutter Cancer Center and Codirector of its Melanoma Program at NYU Langone Medical Center. Medical oncologist and translational clinical trialist with an interest in melanoma immunotherapy and its intersection with targeted therapy.
Physician-scientist and former Head of Translational Medicine at Roche/Genentech, with broad experience in drug early and late clinical development from over 50 programs. Dr. Pisa has in-depth knowledge of the experimental and clinical challenges with real-life experience of successful translation of scientific findings into medicines and innovative treatment modalities. Dr. Pisa has behind him a […]